 | • レポートコード：MRC2-11QY12591 • 出版社/出版日：QYResearch / 2020年11月25日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、92ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料はマールブルグウイルス感染症のグローバル市場について調査・分析したレポートです。種類別（エリトラン四ナトリウム、AR-12、ARD-5、AVI-7288、その他）市場規模、用途別（病院、クリニック、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別マールブルグウイルス感染症の競争状況、市場シェア ・世界のマールブルグウイルス感染症市場：種類別市場規模 2015年-2020年（エリトラン四ナトリウム、AR-12、ARD-5、AVI-7288、その他） ・世界のマールブルグウイルス感染症市場：種類別市場規模予測 2021年-2026年（エリトラン四ナトリウム、AR-12、ARD-5、AVI-7288、その他） ・世界のマールブルグウイルス感染症市場：用途別市場規模 2015年-2020年（病院、クリニック、その他） ・世界のマールブルグウイルス感染症市場：用途別市場規模予測 2021年-2026年（病院、クリニック、その他） ・北米のマールブルグウイルス感染症市場分析：米国、カナダ ・ヨーロッパのマールブルグウイルス感染症市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアのマールブルグウイルス感染症市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米のマールブルグウイルス感染症市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカのマールブルグウイルス感染症市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Arno Therapeutics Inc、BioCryst Pharmaceuticals Inc、Eisai Co Ltd、Emergent BioSolutions Inc、Fab'entech SA、Integrated BioTherapeutics Inc、Johnson & Johnson、NanoViricides Inc、Profectus BioSciences Inc、Rodos BioTarget GmbH、Sarepta Therapeutics Inc、Theravectys SA ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Market Analysis and Insights: Global Marburgvirus Infection Market
The global Marburgvirus Infection market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Marburgvirus Infection Scope and Market Size
Marburgvirus Infection market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Marburgvirus Infection market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Arno Therapeutics Inc
BioCryst Pharmaceuticals Inc
Eisai Co Ltd
Emergent BioSolutions Inc
Fab’entech SA
Integrated BioTherapeutics Inc
Johnson & Johnson
NanoViricides Inc
Profectus BioSciences Inc
Rodos BioTarget GmbH
Sarepta Therapeutics Inc
Theravectys SA
Market segment by Type, the product can be split into
Eritoran Tetrasodium
AR-12
ARD-5
AVI-7288
Others
Market segment by Application, split into
Hospital
Clinic
Others
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Marburgvirus Infection Revenue
1.4 Market by Type
1.4.1 Global Marburgvirus Infection Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Eritoran Tetrasodium
1.4.3 AR-12
1.4.4 ARD-5
1.4.5 AVI-7288
1.4.6 Others
1.5 Market by Application
1.5.1 Global Marburgvirus Infection Market Share by Application: 2020 VS 2026
1.5.2 Hospital
1.5.3 Clinic
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Marburgvirus Infection Market Perspective (2015-2026)
2.2 Global Marburgvirus Infection Growth Trends by Regions
2.2.1 Marburgvirus Infection Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Marburgvirus Infection Historic Market Share by Regions (2015-2020)
2.2.3 Marburgvirus Infection Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Marburgvirus Infection Market Growth Strategy
2.3.6 Primary Interviews with Key Marburgvirus Infection Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Marburgvirus Infection Players by Market Size
3.1.1 Global Top Marburgvirus Infection Players by Revenue (2015-2020)
3.1.2 Global Marburgvirus Infection Revenue Market Share by Players (2015-2020)
3.1.3 Global Marburgvirus Infection Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Marburgvirus Infection Market Concentration Ratio
3.2.1 Global Marburgvirus Infection Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Marburgvirus Infection Revenue in 2019
3.3 Marburgvirus Infection Key Players Head office and Area Served
3.4 Key Players Marburgvirus Infection Product Solution and Service
3.5 Date of Enter into Marburgvirus Infection Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Marburgvirus Infection Historic Market Size by Type (2015-2020)
4.2 Global Marburgvirus Infection Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Marburgvirus Infection Market Size by Application (2015-2020)
5.2 Global Marburgvirus Infection Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Marburgvirus Infection Market Size (2015-2020)
6.2 Marburgvirus Infection Key Players in North America (2019-2020)
6.3 North America Marburgvirus Infection Market Size by Type (2015-2020)
6.4 North America Marburgvirus Infection Market Size by Application (2015-2020)
7 Europe
7.1 Europe Marburgvirus Infection Market Size (2015-2020)
7.2 Marburgvirus Infection Key Players in Europe (2019-2020)
7.3 Europe Marburgvirus Infection Market Size by Type (2015-2020)
7.4 Europe Marburgvirus Infection Market Size by Application (2015-2020)
8 China
8.1 China Marburgvirus Infection Market Size (2015-2020)
8.2 Marburgvirus Infection Key Players in China (2019-2020)
8.3 China Marburgvirus Infection Market Size by Type (2015-2020)
8.4 China Marburgvirus Infection Market Size by Application (2015-2020)
9 Japan
9.1 Japan Marburgvirus Infection Market Size (2015-2020)
9.2 Marburgvirus Infection Key Players in Japan (2019-2020)
9.3 Japan Marburgvirus Infection Market Size by Type (2015-2020)
9.4 Japan Marburgvirus Infection Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Marburgvirus Infection Market Size (2015-2020)
10.2 Marburgvirus Infection Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Marburgvirus Infection Market Size by Type (2015-2020)
10.4 Southeast Asia Marburgvirus Infection Market Size by Application (2015-2020)
11 India
11.1 India Marburgvirus Infection Market Size (2015-2020)
11.2 Marburgvirus Infection Key Players in India (2019-2020)
11.3 India Marburgvirus Infection Market Size by Type (2015-2020)
11.4 India Marburgvirus Infection Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Marburgvirus Infection Market Size (2015-2020)
12.2 Marburgvirus Infection Key Players in Central & South America (2019-2020)
12.3 Central & South America Marburgvirus Infection Market Size by Type (2015-2020)
12.4 Central & South America Marburgvirus Infection Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Arno Therapeutics Inc
13.1.1 Arno Therapeutics Inc Company Details
13.1.2 Arno Therapeutics Inc Business Overview
13.1.3 Arno Therapeutics Inc Marburgvirus Infection Introduction
13.1.4 Arno Therapeutics Inc Revenue in Marburgvirus Infection Business (2015-2020))
13.1.5 Arno Therapeutics Inc Recent Development
13.2 BioCryst Pharmaceuticals Inc
13.2.1 BioCryst Pharmaceuticals Inc Company Details
13.2.2 BioCryst Pharmaceuticals Inc Business Overview
13.2.3 BioCryst Pharmaceuticals Inc Marburgvirus Infection Introduction
13.2.4 BioCryst Pharmaceuticals Inc Revenue in Marburgvirus Infection Business (2015-2020)
13.2.5 BioCryst Pharmaceuticals Inc Recent Development
13.3 Eisai Co Ltd
13.3.1 Eisai Co Ltd Company Details
13.3.2 Eisai Co Ltd Business Overview
13.3.3 Eisai Co Ltd Marburgvirus Infection Introduction
13.3.4 Eisai Co Ltd Revenue in Marburgvirus Infection Business (2015-2020)
13.3.5 Eisai Co Ltd Recent Development
13.4 Emergent BioSolutions Inc
13.4.1 Emergent BioSolutions Inc Company Details
13.4.2 Emergent BioSolutions Inc Business Overview
13.4.3 Emergent BioSolutions Inc Marburgvirus Infection Introduction
13.4.4 Emergent BioSolutions Inc Revenue in Marburgvirus Infection Business (2015-2020)
13.4.5 Emergent BioSolutions Inc Recent Development
13.5 Fab’entech SA
13.5.1 Fab’entech SA Company Details
13.5.2 Fab’entech SA Business Overview
13.5.3 Fab’entech SA Marburgvirus Infection Introduction
13.5.4 Fab’entech SA Revenue in Marburgvirus Infection Business (2015-2020)
13.5.5 Fab’entech SA Recent Development
13.6 Integrated BioTherapeutics Inc
13.6.1 Integrated BioTherapeutics Inc Company Details
13.6.2 Integrated BioTherapeutics Inc Business Overview
13.6.3 Integrated BioTherapeutics Inc Marburgvirus Infection Introduction
13.6.4 Integrated BioTherapeutics Inc Revenue in Marburgvirus Infection Business (2015-2020)
13.6.5 Integrated BioTherapeutics Inc Recent Development
13.7 Johnson & Johnson
13.7.1 Johnson & Johnson Company Details
13.7.2 Johnson & Johnson Business Overview
13.7.3 Johnson & Johnson Marburgvirus Infection Introduction
13.7.4 Johnson & Johnson Revenue in Marburgvirus Infection Business (2015-2020)
13.7.5 Johnson & Johnson Recent Development
13.8 NanoViricides Inc
13.8.1 NanoViricides Inc Company Details
13.8.2 NanoViricides Inc Business Overview
13.8.3 NanoViricides Inc Marburgvirus Infection Introduction
13.8.4 NanoViricides Inc Revenue in Marburgvirus Infection Business (2015-2020)
13.8.5 NanoViricides Inc Recent Development
13.9 Profectus BioSciences Inc
13.9.1 Profectus BioSciences Inc Company Details
13.9.2 Profectus BioSciences Inc Business Overview
13.9.3 Profectus BioSciences Inc Marburgvirus Infection Introduction
13.9.4 Profectus BioSciences Inc Revenue in Marburgvirus Infection Business (2015-2020)
13.9.5 Profectus BioSciences Inc Recent Development
13.10 Rodos BioTarget GmbH
13.10.1 Rodos BioTarget GmbH Company Details
13.10.2 Rodos BioTarget GmbH Business Overview
13.10.3 Rodos BioTarget GmbH Marburgvirus Infection Introduction
13.10.4 Rodos BioTarget GmbH Revenue in Marburgvirus Infection Business (2015-2020)
13.10.5 Rodos BioTarget GmbH Recent Development
13.11 Sarepta Therapeutics Inc
10.11.1 Sarepta Therapeutics Inc Company Details
10.11.2 Sarepta Therapeutics Inc Business Overview
10.11.3 Sarepta Therapeutics Inc Marburgvirus Infection Introduction
10.11.4 Sarepta Therapeutics Inc Revenue in Marburgvirus Infection Business (2015-2020)
10.11.5 Sarepta Therapeutics Inc Recent Development
13.12 Theravectys SA
10.12.1 Theravectys SA Company Details
10.12.2 Theravectys SA Business Overview
10.12.3 Theravectys SA Marburgvirus Infection Introduction
10.12.4 Theravectys SA Revenue in Marburgvirus Infection Business (2015-2020)
10.12.5 Theravectys SA Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Marburgvirus Infection Key Market Segments
Table 2. Key Players Covered: Ranking by Marburgvirus Infection Revenue
Table 3. Ranking of Global Top Marburgvirus Infection Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Marburgvirus Infection Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Eritoran Tetrasodium
Table 6. Key Players of AR-12
Table 7. Key Players of ARD-5
Table 8. Key Players of AVI-7288
Table 9. Key Players of Others
Table 10. Global Marburgvirus Infection Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 11. Global Marburgvirus Infection Market Size by Regions (US$ Million): 2020 VS 2026
Table 12. Global Marburgvirus Infection Market Size by Regions (2015-2020) (US$ Million)
Table 13. Global Marburgvirus Infection Market Share by Regions (2015-2020)
Table 14. Global Marburgvirus Infection Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 15. Global Marburgvirus Infection Market Share by Regions (2021-2026)
Table 16. Market Top Trends
Table 17. Key Drivers: Impact Analysis
Table 18. Key Challenges
Table 19. Marburgvirus Infection Market Growth Strategy
Table 20. Main Points Interviewed from Key Marburgvirus Infection Players
Table 21. Global Marburgvirus Infection Revenue by Players (2015-2020) (Million US$)
Table 22. Global Marburgvirus Infection Market Share by Players (2015-2020)
Table 23. Global Top Marburgvirus Infection Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Marburgvirus Infection as of 2019)
Table 24. Global Marburgvirus Infection by Players Market Concentration Ratio (CR5 and HHI)
Table 25. Key Players Headquarters and Area Served
Table 26. Key Players Marburgvirus Infection Product Solution and Service
Table 27. Date of Enter into Marburgvirus Infection Market
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Marburgvirus Infection Market Size by Type (2015-2020) (Million US$)
Table 30. Global Marburgvirus Infection Market Size Share by Type (2015-2020)
Table 31. Global Marburgvirus Infection Revenue Market Share by Type (2021-2026)
Table 32. Global Marburgvirus Infection Market Size Share by Application (2015-2020)
Table 33. Global Marburgvirus Infection Market Size by Application (2015-2020) (Million US$)
Table 34. Global Marburgvirus Infection Market Size Share by Application (2021-2026)
Table 35. North America Key Players Marburgvirus Infection Revenue (2019-2020) (Million US$)
Table 36. North America Key Players Marburgvirus Infection Market Share (2019-2020)
Table 37. North America Marburgvirus Infection Market Size by Type (2015-2020) (Million US$)
Table 38. North America Marburgvirus Infection Market Share by Type (2015-2020)
Table 39. North America Marburgvirus Infection Market Size by Application (2015-2020) (Million US$)
Table 40. North America Marburgvirus Infection Market Share by Application (2015-2020)
Table 41. Europe Key Players Marburgvirus Infection Revenue (2019-2020) (Million US$)
Table 42. Europe Key Players Marburgvirus Infection Market Share (2019-2020)
Table 43. Europe Marburgvirus Infection Market Size by Type (2015-2020) (Million US$)
Table 44. Europe Marburgvirus Infection Market Share by Type (2015-2020)
Table 45. Europe Marburgvirus Infection Market Size by Application (2015-2020) (Million US$)
Table 46. Europe Marburgvirus Infection Market Share by Application (2015-2020)
Table 47. China Key Players Marburgvirus Infection Revenue (2019-2020) (Million US$)
Table 48. China Key Players Marburgvirus Infection Market Share (2019-2020)
Table 49. China Marburgvirus Infection Market Size by Type (2015-2020) (Million US$)
Table 50. China Marburgvirus Infection Market Share by Type (2015-2020)
Table 51. China Marburgvirus Infection Market Size by Application (2015-2020) (Million US$)
Table 52. China Marburgvirus Infection Market Share by Application (2015-2020)
Table 53. Japan Key Players Marburgvirus Infection Revenue (2019-2020) (Million US$)
Table 54. Japan Key Players Marburgvirus Infection Market Share (2019-2020)
Table 55. Japan Marburgvirus Infection Market Size by Type (2015-2020) (Million US$)
Table 56. Japan Marburgvirus Infection Market Share by Type (2015-2020)
Table 57. Japan Marburgvirus Infection Market Size by Application (2015-2020) (Million US$)
Table 58. Japan Marburgvirus Infection Market Share by Application (2015-2020)
Table 59. Southeast Asia Key Players Marburgvirus Infection Revenue (2019-2020) (Million US$)
Table 60. Southeast Asia Key Players Marburgvirus Infection Market Share (2019-2020)
Table 61. Southeast Asia Marburgvirus Infection Market Size by Type (2015-2020) (Million US$)
Table 62. Southeast Asia Marburgvirus Infection Market Share by Type (2015-2020)
Table 63. Southeast Asia Marburgvirus Infection Market Size by Application (2015-2020) (Million US$)
Table 64. Southeast Asia Marburgvirus Infection Market Share by Application (2015-2020)
Table 65. India Key Players Marburgvirus Infection Revenue (2019-2020) (Million US$)
Table 66. India Key Players Marburgvirus Infection Market Share (2019-2020)
Table 67. India Marburgvirus Infection Market Size by Type (2015-2020) (Million US$)
Table 68. India Marburgvirus Infection Market Share by Type (2015-2020)
Table 69. India Marburgvirus Infection Market Size by Application (2015-2020) (Million US$)
Table 70. India Marburgvirus Infection Market Share by Application (2015-2020)
Table 71. Central & South America Key Players Marburgvirus Infection Revenue (2019-2020) (Million US$)
Table 72. Central & South America Key Players Marburgvirus Infection Market Share (2019-2020)
Table 73. Central & South America Marburgvirus Infection Market Size by Type (2015-2020) (Million US$)
Table 74. Central & South America Marburgvirus Infection Market Share by Type (2015-2020)
Table 75. Central & South America Marburgvirus Infection Market Size by Application (2015-2020) (Million US$)
Table 76. Central & South America Marburgvirus Infection Market Share by Application (2015-2020)
Table 77. Arno Therapeutics Inc Company Details
Table 78. Arno Therapeutics Inc Business Overview
Table 79. Arno Therapeutics Inc Product
Table 80. Arno Therapeutics Inc Revenue in Marburgvirus Infection Business (2015-2020) (Million US$)
Table 81. Arno Therapeutics Inc Recent Development
Table 82. BioCryst Pharmaceuticals Inc Company Details
Table 83. BioCryst Pharmaceuticals Inc Business Overview
Table 84. BioCryst Pharmaceuticals Inc Product
Table 85. BioCryst Pharmaceuticals Inc Revenue in Marburgvirus Infection Business (2015-2020) (Million US$)
Table 86. BioCryst Pharmaceuticals Inc Recent Development
Table 87. Eisai Co Ltd Company Details
Table 88. Eisai Co Ltd Business Overview
Table 89. Eisai Co Ltd Product
Table 90. Eisai Co Ltd Revenue in Marburgvirus Infection Business (2015-2020) (Million US$)
Table 91. Eisai Co Ltd Recent Development
Table 92. Emergent BioSolutions Inc Company Details
Table 93. Emergent BioSolutions Inc Business Overview
Table 94. Emergent BioSolutions Inc Product
Table 95. Emergent BioSolutions Inc Revenue in Marburgvirus Infection Business (2015-2020) (Million US$)
Table 96. Emergent BioSolutions Inc Recent Development
Table 97. Fab'entech SA Company Details
Table 98. Fab'entech SA Business Overview
Table 99. Fab'entech SA Product
Table 100. Fab'entech SA Revenue in Marburgvirus Infection Business (2015-2020) (Million US$)
Table 101. Fab'entech SA Recent Development
Table 102. Integrated BioTherapeutics Inc Company Details
Table 103. Integrated BioTherapeutics Inc Business Overview
Table 104. Integrated BioTherapeutics Inc Product
Table 105. Integrated BioTherapeutics Inc Revenue in Marburgvirus Infection Business (2015-2020) (Million US$)
Table 106. Integrated BioTherapeutics Inc Recent Development
Table 107. Johnson & Johnson Company Details
Table 108. Johnson & Johnson Business Overview
Table 109. Johnson & Johnson Product
Table 110. Johnson & Johnson Revenue in Marburgvirus Infection Business (2015-2020) (Million US$)
Table 111. Johnson & Johnson Recent Development
Table 112. NanoViricides Inc Business Overview
Table 113. NanoViricides Inc Product
Table 114. NanoViricides Inc Company Details
Table 115. NanoViricides Inc Revenue in Marburgvirus Infection Business (2015-2020) (Million US$)
Table 116. NanoViricides Inc Recent Development
Table 117. Profectus BioSciences Inc Company Details
Table 118. Profectus BioSciences Inc Business Overview
Table 119. Profectus BioSciences Inc Product
Table 120. Profectus BioSciences Inc Revenue in Marburgvirus Infection Business (2015-2020) (Million US$)
Table 121. Profectus BioSciences Inc Recent Development
Table 122. Rodos BioTarget GmbH Company Details
Table 123. Rodos BioTarget GmbH Business Overview
Table 124. Rodos BioTarget GmbH Product
Table 125. Rodos BioTarget GmbH Revenue in Marburgvirus Infection Business (2015-2020) (Million US$)
Table 126. Rodos BioTarget GmbH Recent Development
Table 127. Sarepta Therapeutics Inc Company Details
Table 128. Sarepta Therapeutics Inc Business Overview
Table 129. Sarepta Therapeutics Inc Product
Table 130. Sarepta Therapeutics Inc Revenue in Marburgvirus Infection Business (2015-2020) (Million US$)
Table 131. Sarepta Therapeutics Inc Recent Development
Table 132. Theravectys SA Company Details
Table 133. Theravectys SA Business Overview
Table 134. Theravectys SA Product
Table 135. Theravectys SA Revenue in Marburgvirus Infection Business (2015-2020) (Million US$)
Table 136. Theravectys SA Recent Development
Table 137. Research Programs/Design for This Report
Table 138. Key Data Information from Secondary Sources
Table 139. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Marburgvirus Infection Market Share by Type: 2020 VS 2026
Figure 2. Eritoran Tetrasodium Features
Figure 3. AR-12 Features
Figure 4. ARD-5 Features
Figure 5. AVI-7288 Features
Figure 6. Others Features
Figure 7. Global Marburgvirus Infection Market Share by Application: 2020 VS 2026
Figure 8. Hospital Case Studies
Figure 9. Clinic Case Studies
Figure 10. Others Case Studies
Figure 11. Marburgvirus Infection Report Years Considered
Figure 12. Global Marburgvirus Infection Market Size YoY Growth 2015-2026 (US$ Million)
Figure 13. Global Marburgvirus Infection Market Share by Regions: 2020 VS 2026
Figure 14. Global Marburgvirus Infection Market Share by Regions (2021-2026)
Figure 15. Porter's Five Forces Analysis
Figure 16. Global Marburgvirus Infection Market Share by Players in 2019
Figure 17. Global Top Marburgvirus Infection Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Marburgvirus Infection as of 2019
Figure 18. The Top 10 and 5 Players Market Share by Marburgvirus Infection Revenue in 2019
Figure 19. North America Marburgvirus Infection Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Europe Marburgvirus Infection Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. China Marburgvirus Infection Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Japan Marburgvirus Infection Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Southeast Asia Marburgvirus Infection Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. India Marburgvirus Infection Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Central & South America Marburgvirus Infection Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. Bottom-up and Top-down Approaches for This Report
Figure 27. Data Triangulation
Figure 28. Key Executives Interviewed
医療関連感染（HAI）管理の世界市場（～2026年） A hospital-acquired infection (HAI), also known as a nosocomial infection, is an infection that is acquired in a hospital or other health care facility. The rise in the incidences of different types of hospital acquired infections, innovative technologies implemented in devices that control infectio…- 院内感染治療の世界市場（～2026年） Hospital-acquired infections, also known as nosocomial infections, are acquired by patients in the hospitals or healthcare facilities. Urinary tract infections, bloodstream infections, surgical-site infections, Clostridium difficile associated diarrhea, and pneumonia are examples of nosocomial infec…
- 医療関連感染（HAI）治療の世界市場（～2026年） Hospital Acquired Infection Treatment is an infection that is acquired in a hospital or other health care facility. Market Analysis and Insights: Global Hospital Acquired Infection Treatment Market The global Hospital Acquired Infection Treatment market size is projected to reach US$ 19430 million b…
- 尿路感染症治療の世界市場（～2026年） Urinary tract infection (UTI) is a common infections of the urinary tract, which consists of the kidneys, ureters, bladder, urethra or prostate gland. This trend of increment in the prevalence rate of diabetes among adults is expected to continue during the forecast period. Therefore, with increasin…
- サイトメガロウイルス（CMV）感染症の世界市場（～2026年） Cytomegalovirus (CMV) infection is one of the common herpesvirus infection with different symptoms, which occurs in people of all ages across the globe. This viral infection is communicable and can easily spread through body fluids such as blood, urine, saliva, semen and breast milk. The infection c…